Legend Biotech CorporationLEGNNASDAQ
Loading
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +66.86% | +134.73% | +107.52% | +36.74% | +69.99% |
| Gross Profit Growth | +121.13% | +139.50% | +215.17% | +15.43% | +49.92% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +0.52% | +0.52% | +0.97% | +0.84% | -1.27% |
| Weighted Average Shares Diluted Growth | +0.52% | +0.52% | +0.97% | +0.84% | +1.05% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | -768.60% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | -1240.47% | +0.00% | +0.00% |
| Receivables Growth | +109.27% | -20.48% | +114.03% | +125.89% | -98.75% |
| Inventory Growth | +30.72% | +23.00% | +39.68% | +88.60% | +23.93% |
| Asset Growth | -5.63% | -9.65% | -8.98% | -6.02% | -1.32% |
| Book Value per Share Growth | -17.11% | -17.28% | -13.41% | -11.40% | -8.23% |
| Debt Growth | +8.14% | +6.67% | +8.40% | +14.45% | +18.36% |
| R&D Expense Growth | -0.35% | -1.18% | +0.95% | -12.72% | +18.45% |
| SG&A Expenses Growth | +80.71% | +33.25% | +28.99% | +23.28% | +9.75% |